A detailed history of Shorepoint Capital Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Shorepoint Capital Partners LLC holds 35,162 shares of JNJ stock, worth $5.13 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
35,162
Previous 36,005 2.34%
Holding current value
$5.13 Million
Previous $5.26 Million 8.29%
% of portfolio
1.34%
Previous 1.26%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $122,639 - $141,101
-843 Reduced 2.34%
35,162 $5.7 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $37,538 - $41,022
260 Added 0.73%
36,005 $5.26 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $71,556 - $75,023
-461 Reduced 1.27%
35,745 $5.65 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $23,587 - $25,738
-162 Reduced 0.45%
36,206 $5.67 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $33,953 - $38,036
-218 Reduced 0.6%
36,368 $5.66 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $331,235 - $356,472
-2,146 Reduced 5.54%
36,586 $6.06 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $318,111 - $379,627
-2,106 Reduced 5.16%
38,732 $6 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $1.22 Million - $1.37 Million
7,629 Added 22.97%
40,838 $7.21 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $84,214 - $93,709
522 Added 1.6%
33,209 $5.43 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $221,169 - $244,603
-1,315 Reduced 3.87%
32,687 $5.8 Million
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $117,498 - $133,435
-743 Reduced 2.14%
34,002 $6.03 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $148,601 - $164,878
-953 Reduced 2.67%
34,745 $5.94 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $591,574 - $657,398
3,663 Added 11.43%
35,698 $5.77 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $101,179 - $112,687
661 Added 2.11%
32,035 $5.27 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $39,487 - $45,325
288 Added 0.93%
31,374 $4.94 Million
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $179,686 - $196,902
1,280 Added 4.29%
31,086 $4.63 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $126,491 - $152,710
-982 Reduced 3.19%
29,806 $4.19 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $252,510 - $349,865
-2,272 Reduced 6.87%
30,788 $4.04 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $169,065 - $194,179
-1,326 Reduced 3.86%
33,060 $4.82 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $455,115 - $509,571
-3,585 Reduced 9.44%
34,386 $4.45 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $363,941 - $400,266
-2,775 Reduced 6.81%
37,971 $5.29 Million
Q1 2019

Apr 12, 2019

BUY
$125.72 - $139.79 $5.12 Million - $5.7 Million
40,746 New
40,746 $5.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Shorepoint Capital Partners LLC Portfolio

Follow Shorepoint Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shorepoint Capital Partners LLC with notifications on news.